LIGHT CHAIN RESTRICTION ANALYSIS OF BONE-MARROW PLASMA-CELLS IN PATIENTS WITH MGUS OR SOLITARY PLASMACYTOMA - DIAGNOSTIC-VALUE AND CORRELATION WITH CLINICAL COURSE

被引:5
作者
BEZWODA, WR
GORDON, V
BAGG, A
MENDELOW, B
机构
[1] UNIV WITWATERSRAND,SCH MED,DEPT HAEMATOL,JOHANNESBURG 2001,SOUTH AFRICA
[2] S AFRICAN INST MED RES,JOHANNESBURG 2000,SOUTH AFRICA
关键词
D O I
10.1111/j.1365-2141.1990.tb06329.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Twenty‐eight patients with a diagnosis of ‘solitary’ plasmacytoma or with gammopathy but with nondiagnostic morphologic examination of the bone marrow were investigated using a short‐term bone marrow culture technique which enriched for the plasma cell fraction. The percentage of monotypic plasma cells in these plasma cell enriched cultures was correlated with the subsequent clinical course. The majority of patients with plasmacytoma and a significant number of those with gammopathy but with otherwise non‐diagnostic investigations were found to have a monoclonal plasma cell component of >20%. There was a significant correlation between the percentage of monoclonal plasma cells as detected by bone marrow culture and subsequent progression to disseminated myeloma. These results indicate that early bone marrow involvement can be detected by means of plasma cell culture prior to morphologic identification of marrow plasmacytosis and that short‐term plasma cell culture distinguishes patients with early, low bulk myeloma from those with monoclonal gammopathy of uncertain significance (MGUS). Copyright © 1990, Wiley Blackwell. All rights reserved
引用
收藏
页码:420 / 423
页数:4
相关论文
共 17 条
[1]   CIRCULATING MONOTYPIC B-CELLS IN MULTIPLE-MYELOMA - ASSOCIATION WITH LAMBDA PARAPROTEINS [J].
BAGG, A ;
BECKER, P ;
BEZWODA, W ;
VANRENSBURG, L ;
MENDELOW, B .
BRITISH JOURNAL OF HAEMATOLOGY, 1989, 72 (02) :167-172
[2]  
BERGSAGEL DE, 1973, CANCER CHEMOTH REP, V4, P145
[3]   SOLITARY PLASMACYTOMA OF BONE - TREATMENT, PROGRESSION, AND SURVIVAL [J].
CHAK, LY ;
COX, RS ;
BOSTWICK, DG ;
HOPPE, RT .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (11) :1811-1815
[4]   MELPHALAN AND PREDNISONE - EFFECTIVE COMBINATION FOR TREATMENT OF MULTIPLE-MYELOMA [J].
COSTA, G ;
ENGLE, RL ;
SCHILLING, A ;
CARBONE, P ;
KOCHWA, S ;
NACHMAN, RL ;
GLIDEWELL, O .
AMERICAN JOURNAL OF MEDICINE, 1973, 54 (05) :589-599
[5]  
DELAUCHECAVALLIER MC, 1988, CANCER, V61, P1707, DOI 10.1002/1097-0142(19880415)61:8<1707::AID-CNCR2820610832>3.0.CO
[6]  
2-N
[7]  
DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO
[8]  
2-U
[9]  
GORDON V, 1985, AM J HEMATOL, V23, P81
[10]  
Hallen J, 1966, Acta Med Scand Suppl, V462, P1